Supported by Inner Mongolia Natural Science Foundation and the 3rd Affiliated of Inner Medical University,No.2021MS08067.
BACKGROUND Pancreatic cancer(PC)is one of the most aggressive malignancies characterized by rapid progression and poor prognosis.The involvement of cancer stem cells(CSCs)and Octamer transcription factor 4(OCT4)in PC ...
BACKGROUND Over the years,the numbers of treatment options for colorectal cancer(CRC)have increased,leading to notable improvements in the overall survival of CRC patients.Although therapy may initially yield positive...
supported by the National Key Research and De-velopment Program of China(2022YFB3804500);the Shanghai Pilot Program for Basic Research-Chinese Academy of Sciences,Shanghai Branch(JCYJ-SHFY-2022-003);the National Natu-ral Science Foundation of China(22335006 and 32101090);the China Postdoctoral Science Foundation(2024M763409);the Shanghai Rising-Star Project(Sailing Program)(24YF2753400);the Key Research Program of Frontier Sciences,Chinese Academy of Sciences(ZDBS-LY-SLH029).
Cancer stem-li ke cel ls(CSCs),featuring high tumorigenicity and invasiveness,are one of the critical factors leading to the failure of clinical cancer treatment such as metastasis and recurrence.However,current strat...
supported by the Special Construction Project Fund for Taishan Mountain Scholars of Shandong Province;the Jinan Medicine Research Program;the Nurturing and Development Fund from The Second Hospital of Shandong University(No.2022YP62);the Shandong Provincial Natural Science Foundation for Young Scholars(No.ZR2022QH285),China.
Hexavalent chromium Cr(Ⅵ),as a well-established carcinogen,contributes to tumorigenesis for many human cancers,especially respiratory and digestive tumors.However,the potential function and relevant mechanism of Cr(...
support from the Deutsche Forschungsgemeinschaft(DFG,German Research Foundation)project no 395357507-SFB 1371.
An increased intestinal stem cell activity following post fastrefeeding is beneficial for regeneration,but too much could increase the risk for cancer in mice,as reported in a recent study by Imada and colleagues publ...
Supported by the National Natural Science Foundation of China,No.82271628.
BACKGROUND Hepatocellular carcinoma(HCC)is a prevalent and aggressive tumor.Sorafenib is the first-line treatment for patients with advanced HCC,but resistance to sorafenib has become a significant challenge in this t...
the National Key Research and Development Program of China(No.2023YFC2306803);the China National Natural Science Foundation(No.82273238,82272975,82072286);the Innovative and Entrepreneurial Team of Chongqing Talents Plan,Chongqing Medical Scientific Research Project(Joint Project of Chongqing Health Commission and Science and Technology Bureau;No.2023DBXM007);Senior Medical Talents Program of Chongqing for Young and Middle-aged,the Kuanren Talents and DengFeng program of the Second Affiliated Hospital of Chongqing Medical University(China),the Future Medical Youth Innovation Team of Chongqing Medical University(China)(No.W0036,W0101);the Postdoctoral Fellowship Program of China Postdoctoral Science Foundation(No.GZC20233349).
Cancer stem cells(CSCs)play a crucial role in tumor initiation,recurrence,metastasis,and drug resistance.However,the current understanding of CSCs in hepatocellular carcinoma(HCC)remains incomplete.Through a comprehen...
National Key Research and Development Program of China(2022YFA1106800),National Natural Science Foundation of China(82203070,82200726,82200727,92159202 and 82273270);Project of Medical and Health Technology Program in Zhejiang Province(2024KY853).
Lenvatinib is a targeted drug used for first-line treatment of hepatocellular carcinoma(HCC).A deeper insight into the resistance mechanism of HCC against lenvatinib is urgently needed.In this study,we aimed to dissec...
Hepatocellular carcinoma(HCC)is a highly heterogeneous tumor,with dynamic equilibrium and complex interplay between its intricate tumor nature and ambient tumor immune microenvironment(TIME).1 Elegant research has ind...
the National Natural Science Foundation of China(No.82272939,82071559);the Capital’s Funds for Health Improvement and Research(China)(2022-2Z-1076);Beijing Hospitals Authority Youth Programme of China(QML20200502).
Enhancer of zeste homolog 2(EZH2),an epigenetic regulator that inhibits transcription primarily through trimethylation of Lys-27 in histone 3(H3K27me3),has been reported to play an important role in the regulation of ...